Cargando…
Clinical response to discontinuation of anti-tumor necrosis factor therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834029/ http://dx.doi.org/10.1186/ar1551 |
_version_ | 1782178524024537088 |
---|---|
author | Baraliakos, X Listing, J Brandt, J Rudwaleit, M Sieper, J Braun, J |
author_facet | Baraliakos, X Listing, J Brandt, J Rudwaleit, M Sieper, J Braun, J |
author_sort | Baraliakos, X |
collection | PubMed |
description | |
format | Text |
id | pubmed-2834029 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-28340292010-03-08 Clinical response to discontinuation of anti-tumor necrosis factor therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab Baraliakos, X Listing, J Brandt, J Rudwaleit, M Sieper, J Braun, J Arthritis Res Ther Poster Presentation BioMed Central 2005 2005-02-17 /pmc/articles/PMC2834029/ http://dx.doi.org/10.1186/ar1551 Text en Copyright ©2005 BioMed Central Ltd |
spellingShingle | Poster Presentation Baraliakos, X Listing, J Brandt, J Rudwaleit, M Sieper, J Braun, J Clinical response to discontinuation of anti-tumor necrosis factor therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab |
title | Clinical response to discontinuation of anti-tumor necrosis factor therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab |
title_full | Clinical response to discontinuation of anti-tumor necrosis factor therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab |
title_fullStr | Clinical response to discontinuation of anti-tumor necrosis factor therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab |
title_full_unstemmed | Clinical response to discontinuation of anti-tumor necrosis factor therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab |
title_short | Clinical response to discontinuation of anti-tumor necrosis factor therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab |
title_sort | clinical response to discontinuation of anti-tumor necrosis factor therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834029/ http://dx.doi.org/10.1186/ar1551 |
work_keys_str_mv | AT baraliakosx clinicalresponsetodiscontinuationofantitumornecrosisfactortherapyinpatientswithankylosingspondylitisafter3yearsofcontinuoustreatmentwithinfliximab AT listingj clinicalresponsetodiscontinuationofantitumornecrosisfactortherapyinpatientswithankylosingspondylitisafter3yearsofcontinuoustreatmentwithinfliximab AT brandtj clinicalresponsetodiscontinuationofantitumornecrosisfactortherapyinpatientswithankylosingspondylitisafter3yearsofcontinuoustreatmentwithinfliximab AT rudwaleitm clinicalresponsetodiscontinuationofantitumornecrosisfactortherapyinpatientswithankylosingspondylitisafter3yearsofcontinuoustreatmentwithinfliximab AT sieperj clinicalresponsetodiscontinuationofantitumornecrosisfactortherapyinpatientswithankylosingspondylitisafter3yearsofcontinuoustreatmentwithinfliximab AT braunj clinicalresponsetodiscontinuationofantitumornecrosisfactortherapyinpatientswithankylosingspondylitisafter3yearsofcontinuoustreatmentwithinfliximab |